Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $5.9 million.

  • Conmed's Change in Accured Expenses rose 5525.56% to $5.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $14.9 million, marking a year-over-year increase of 45105.93%. This contributed to the annual value of $14.9 million for FY2025, which is 45105.93% up from last year.
  • Conmed's Change in Accured Expenses amounted to $5.9 million in Q4 2025, which was up 5525.56% from $13.3 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Change in Accured Expenses ranged from a high of $14.1 million in Q3 2023 and a low of -$19.8 million during Q1 2024
  • In the last 5 years, Conmed's Change in Accured Expenses had a median value of $3.9 million in 2022 and averaged $1.4 million.
  • As far as peak fluctuations go, Conmed's Change in Accured Expenses surged by 136789.25% in 2023, and later tumbled by 34528.08% in 2025.
  • Over the past 5 years, Conmed's Change in Accured Expenses (Quarter) stood at $4.7 million in 2021, then crashed by 115.05% to -$707000.0 in 2022, then skyrocketed by 1367.89% to $9.0 million in 2023, then tumbled by 57.44% to $3.8 million in 2024, then surged by 55.26% to $5.9 million in 2025.
  • Its last three reported values are $5.9 million in Q4 2025, $13.3 million for Q3 2025, and -$14.4 million during Q2 2025.